Barinthus Biotherapeutics Analyst Ratings
Barinthus Biotherapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/28/2023 | 415.46% | HC Wainwright & Co. | → $15 | Reiterates | Buy → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/28/2023 | 415.46% | HC Wainwright & Co. | → 15 美元 | 重申 | 購買 → 購買 |
What is the target price for Barinthus Biotherapeutics (BRNS)?
Barinthus Biotherapeutics（BRNS）的目標價格是多少？
The latest price target for Barinthus Biotherapeutics (NASDAQ: BRNS) was reported by HC Wainwright & Co. on November 28, 2023. The analyst firm set a price target for $15.00 expecting BRNS to rise to within 12 months (a possible 415.46% upside). 1 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年11月28日公佈了Barinthus Biotherapeutics（納斯達克股票代碼：BRNS）的最新目標股價。該分析公司將目標股價定爲15.00美元，預計BRNS將在12個月內升至12個月內（可能上漲415.46％）。1家分析公司去年公佈了評級。
What is the most recent analyst rating for Barinthus Biotherapeutics (BRNS)?
Barinthus Biotherapeutics（BRNS）的最新分析師評級是多少？
The latest analyst rating for Barinthus Biotherapeutics (NASDAQ: BRNS) was provided by HC Wainwright & Co., and Barinthus Biotherapeutics reiterated their buy rating.
HC Wainwright & Co. 提供了Barinthus Biotherapeutics（納斯達克股票代碼：BRNS）的最新分析師評級，Barinthus Biotherapeutics重申了買入評級。
When is the next analyst rating going to be posted or updated for Barinthus Biotherapeutics (BRNS)?
Barinthus Biotherapeutics（BRNS）的下一次分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Barinthus Biotherapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Barinthus Biotherapeutics was filed on November 28, 2023 so you should expect the next rating to be made available sometime around November 28, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Barinthus Biotherapeutics的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Barinthus Biotherapeutics的最新評級是在2023年11月28日公佈的，因此您應該預計下一個評級將在2024年11月28日左右公佈。
Is the Analyst Rating Barinthus Biotherapeutics (BRNS) correct?
分析師對Barinthus Biotherapeutics（BRNS）的評級是否正確？
While ratings are subjective and will change, the latest Barinthus Biotherapeutics (BRNS) rating was a reiterated with a price target of $0.00 to $15.00. The current price Barinthus Biotherapeutics (BRNS) is trading at is $2.91, which is within the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但重申了最新的Barinthus Biotherapeutics（BRNS）評級，目標股價爲0.00美元至15.00美元。Barinthus Biotherapeutics（BRNS）目前的交易價格爲2.91美元，在分析師的預測區間內。